Real-World Financial Toxicity in Patients Receiving Cancer Immunotherapy

The Journal of Clinical Pathways shares the real-world findings of financial toxicity in cancer patients receiving immunotherapy shared by Belong.life at ASCO-SITC.
Study shows that cancer patients who had discussions with their doctors about the financial challenges of receiving immunotherapy before beginning treatment were 37.5% more likely to avoid financial toxicity when receiving cancer immunotherapy treatments. Read more